XML 61 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Stock-Based Compensation Expense

The stock-based compensation expense included in the Company’s Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2024 and 2023 is as follows (in thousands):

 

 

 

Years ended December 31,

 

 

 

2024

 

 

2023

 

Research and development

 

$

16,450

 

 

$

8,797

 

General and administrative

 

 

15,825

 

 

 

10,716

 

 

$

32,275

 

 

$

19,513

 

Summary of Restricted Stock Units Activity

The following table summarizes the activity for the restricted stock units assumed in the AnHeart acquisition for the year ended December 31, 2024.

 

 

Restricted Stock

 

 

 

Units

 

Non-vested at December 31, 2023

 

 

 

RSUs assumed for the acquisition of AnHeart

 

 

2,201,694

 

Granted

 

 

 

Vested

 

 

(618,340

)

Forfeited or canceled

 

 

(163,223

)

Non-vested at December 31, 2024

 

 

1,420,131

 

 

 

 

 

Options with Service, Market, and Performance Conditions  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Stock Option Activity Stock option activity with combined service, market, and performance conditions for employees for the year ended December 31, 2024 is as follows:

 

 

Shares Issuable
Pursuant to
Stock Options

 

Weighted-Average
Exercise Price

 

Weighted-Average
Remaining Contractual
Term (Years)

 

Aggregate Intrinsic
Value (in thousands)

 

Outstanding at December 31, 2023

 

3,815,194

 

$

6.31

 

 

 

 

 

Granted

 

250,000

 

$

3.23

 

 

 

 

 

Forfeited

 

(144,042

)

$

4.60

 

 

 

 

 

Outstanding at December 31, 2024

 

3,921,152

 

$

6.18

 

 

6.74

 

$

328

 

Exercisable at December 31, 2024

 

748,375

 

$

6.87

 

 

5.91

 

$

 

Summary of Grant-date Fair Value of Stock Options Granted

The fair value of the stock options granted with combined service, market, and performance conditions was based on a Monte Carlo simulation with an embedded Black-Sholes pricing model. For the years ended December 31, 2024 and 2023, the fair value was computed using the following assumptions:

 

 

 

December 31,

 

 

2024

 

 

2023

Exercise price

 

$

3.23

 

 

$1.61 - $1.94

Risk-free interest rate

 

 

4.27

%

 

3.40% - 3.92%

Expected volatility

 

 

81

%

 

72% - 73%

Expected term in years

 

 

6.49

 

 

6.17 - 6.30

Dividend

 

0%

 

 

0%

Options with Service Conditions [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Stock Option Activity Stock option activity with service condition only for employees and members of the Company’s Board of Directors for the year ended December 31, 2024 is as follows:

 

 

Shares Issuable
Pursuant to
Stock Options

 

Weighted-Average
Exercise Price

 

Weighted-Average
Remaining Contractual
Term (Years)

 

Aggregate Intrinsic
Value (in thousands)

 

Outstanding at December 31, 2023

 

26,834,045

 

$

3.51

 

 

 

 

 

Options assumed for acquisition of AnHeart

 

13,742,239

 

$

0.90

 

 

 

 

 

Granted

 

20,175,083

 

$

2.50

 

 

 

 

 

Forfeited

 

(1,750,547

)

$

4.12

 

 

 

 

 

Exercised

 

(5,192,263

)

$

0.86

 

 

 

 

 

Outstanding at December 31, 2024

 

53,808,557

 

$

2.70

 

 

7.72

 

$

32,475

 

Exercisable at December 31, 2024

 

24,245,561

 

$

2.90

 

 

6.43

 

$

18,147

 

Summary of Grant-date Fair Value of Stock Options Granted

For stock options granted with only service conditions during the years ended December 31, 2024 and 2023, the inputs in the Black-Scholes option-pricing model to determine the fair value is as follows:

 

 

 

December 31,

 

 

2024

 

2023

Exercise price

 

$0.08 - $3.83

 

$1.61 - $1.94

Risk-free interest rate

 

3.63% - 4.74%

 

3.47% - 4.12%

Expected volatility

 

72% - 75%

 

74% - 75%

Expected term in years

 

2.00 - 6.08

 

5.50 - 6.08

Dividend

 

0%

 

0%